NEWSROOM

Hemp and Cannabis Stocks Gear Up for Election Day (NASDAQ: APHA) (NASDAQ: TLRY) (OTC: RLBD) (NYSE: ACB)

The green wave election year theme is back on the radar, with election day just a week away.

Naturally, the hype is already underway, and the cannabis, hemp, and CBD space has begun to react. But coming days and weeks could represent an interesting opportunity for stocks in the space given that the structural theme of legalization will be front and center.

In addition, polling numbers slant heavily in Biden’s favor and the Biden-Sanders “unity task force” put together a lengthy document of policy recommendations a couple months ago across a wide array of issues that is highly instructive on the pot stock election hype factor.

For example, among the issues that the task force considered was recreational cannabis legalization, calling for the decriminalization of marijuana using executive action. The task force also expressed support for the federal legalization of medical marijuana.

With that in mind, here’s a selection of some of the most active names in the space, including: Aphria Inc. (NASDAQ:APHA), Tilray Inc. (NASDAQ:TLRY), Real Brands Inc. (OTC:RLBD), and Aurora Cannabis Inc. (NYSE:ACB).

 

Aphria Inc. (NASDAQ: APHA) is a leading global cannabis company driven by “an unrelenting commitment to our people, product quality and innovation.”

The company touts itself as one of Canada’s lowest cost producers, produces, supplies and sells medical cannabis. The company is truly powered by sunlight, allowing for the most natural growing conditions available. “We are committed to providing pharma-grade medical cannabis, superior patient care while balancing patient economics and returns to shareholders. We are the first public licensed producer to report positive cash flow from operations and the first to report positive earnings in consecutive quarters.”

Aphria Inc. (NASDAQ: APHA) recently announced it has completed its first certified European Union Good Manufacturing Practices shipment of dried flower from its Aphria One EU GMP facility to its wholly-owned German subsidiary, CC Pharma GmbH, a leading distributor of pharmaceutical products to more than 13,000 pharmacies in Germany.

“Our first EU GMP shipment into Germany represents another significant milestone for Aphria Inc., one that strengthens our position as a leading cannabis company in Germany and in the European Union,” said Irwin D. Simon, Chief Executive Officer, Aphria Inc. “We are leveraging our strong medical platform and multi-faceted German strategy, which combines domestic cultivation, import licenses and large distribution infrastructure, to increase access to high-quality medical cannabis for patients worldwide. We remain excited about future milestones, including the completion of our cultivation facility in Neumünster, Germany, which we expect will be completed in Q2 FY2021.”

Even with that news, the action hasn’t really heated up in the stock, with shares moving net sideways over the past week. Shares of the stock have powered higher over the past month, rallying roughly 8% in that time on strong overall action.

Aphria Inc. (NASDAQ: APHA) pulled in sales of $144.7M in its last reported quarterly financials, representing top line growth of 14.7%. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($400M against $166M).

 

Tilray Inc. (NASDAQ: TLRY) engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. was incorporated in 2018 and is headquartered in Nanaimo, Canada.

One of its key subsidiaries is High Park, which was launched to produce and distribute world-class cannabis brands and products for the Canadian market. Based in Toronto and led by a team with deep experience in cannabis and global consumer brands, High Park has secured the exclusive rights to produce and distribute a broad-based portfolio of cannabis brands and products in Canada, subject to applicable laws and regulations.

Tilray Inc. (NASDAQ: TLRY) recently announced that Australian researchers have published preliminary results finding that one of the company’s GMP-produced products is showing promise reducing nausea and vomiting for cancer patients undergoing chemotherapy in a world’s first clinical trial.

Results published in Annals of Oncology found a significant improvement in the control of chemotherapy-induced nausea and vomiting. A quarter of the patients taking medicinal cannabis experienced no vomiting and nausea, compared to 14 percent of people who took a placebo. The pilot phase of the study ran for two-and-a-half years with 81 participants enrolled. To be included in the study, patients had to have already experienced nausea and vomiting during chemotherapy despite having taken nausea prevention medication.

In total, over the past five days, shares of the stock have dropped by roughly -11% on above average trading volume. All in all, not a particularly friendly tape, but one that may ultimately present some new opportunities.

Tilray Inc. (NASDAQ: TLRY) managed to rope in revenues totaling $50.4M in overall sales during the company’s most recently reported quarterly financial data — a figure that represents a rate of top line growth of 9.8%, as compared to year-ago data in comparable terms. In addition, the company is battling some balance sheet hurdles, with cash levels struggling to keep up with current liabilities ($137.2M against $163.7M, respectively).

 

Real Brands Inc. (OTC: RLBD) frames itself as the result of a 2020 merger with Canadian American Standard Hemp Inc., which brought together industrial scale hemp CBD oil/isolate extraction and processing, CBD oil and isolate wholesaling, and the production and sale of numerous hemp-derived smokable, edible, and topical CBD consumer products.

The company’s “Halo 5” line represents a proprietary chromatography extraction technology utilizing a Simulated Moving Bed (SMB), providing mass production and precise pharmaceutical-grade molecular separation at dramatically reduced costs.

Real Brands Inc. (OTC: RLBD) has completed a reverse merger to acquire Canadian American Standard Hemp Inc., (CASH) effective immediately. Real Brands’ name and trading symbol will be maintained, with CASH shareholders acquiring majority control of Real Brands. CASH will continue to operate as a wholly-owned subsidiary of Real Brands. Thomas Kidrin, CEO of CASH, has been named Chief Executive Officer (CEO) of Real Brands, replacing former Real Brands CEO Jerry Pearring.

“This strategic merger with Real Brands is designed to drive increased shareholder value and provide the public with an opportunity to participate in the growing global hemp-derived CBD market,” stated Thom Kidrin, new CEO of Real Brands. “With access to the capital markets now, we anticipate it will be easier and faster to fund our next phases of expected growth.”

The context for this announcement is a bit of a bid, with shares acting well over the past five days, up about 11% in that timeframe.

Real Brands Inc. (OTC: RLBD) appears to be moving toward widespread commercial scale operations, particularly given its recent strategic activity and the company’s vision and stated plans going forward. That puts RLBD squarely on track for some interesting potential ahead. Given its cheap share pricing, this more speculative name could represent an interesting opportunity.

 

Aurora Cannabis Inc (NYSE: ACB) is one of the most widely diversified players in the cannabis space due to its powerful strategic investments. In addition, the company has demonstrated rapid organic growth and strong execution on strategic M&A, which to date includes at least 15 companies.

However, just drilling down into its core cannabis production operations, Aurora Cannabis Enterprises Inc, trumpets itself as “one of the world’s largest and leading cannabis companies” and a licensed producer of medical cannabis pursuant to ACMPR.

Aurora Cannabis Inc. (NYSE: ACB) most recently announced it has completed the previously filed At-The-Market program. Because of this, the Company has filed a new preliminary short form base shelf prospectus with securities regulators in each of the provinces of Canada, except Quebec, and a corresponding shelf registration statement on Form F–10 with the United States Securities and Exchange Commission.

According to the release, the base shelf prospectus, when made final, will allow the Company to make offerings of up to U.S.$500 million of common shares, preferred shares, warrants, subscription receipts and debt securities, or any combination thereof during the 25-month period that the base shelf prospectus remains effective.

While this is a clear factor, it has been incorporated into a trading tape characterized by a pretty dominant offer, which hasn’t been the type of action ACB shareholders really want to see. In total, over the past five days, shares of the stock have dropped by roughly -12% on above average trading volume. All in all, not a particularly friendly tape, but one that may ultimately present some new opportunities. Over the past month, shares of the stock have suffered from clear selling pressure, dropping by roughly -15%.

Aurora Cannabis Inc. (NYSE: ACB) pulled in sales of $72.1M in its last reported quarterly financials, representing top line growth of -27.1%. In addition, the company is battling some balance sheet hurdles, with cash levels struggling to keep up with current liabilities ($169.2M against $272.8M, respectively).

DISCLAIMER:  EDM Media LLC (EDM), is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  EDM is NOT affiliated in any manner with any company mentioned herein.  EDM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  EDM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  EDM is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed EDM has been compensated seven hundred fifty dollars for news coverage of the current press releases issued by Real Brands Inc. by a third party.

EDM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and EDM undertakes no obligation to update such statements.

Media Contact:

EDM Media LLC

Email: IR@EDM.Media

Office: 800-301-7883

EDM.Media

 

 

 

Categories

Mcap MediaWire - Costumer Service